The Inflation Reduction Act raids an estimated $260 billion in reduced Medicare drug spending to pay for unrelated spending.

In 2025, everyone enrolled in Part D will have their annual out-of-pocket drug costs capped at $2,000. In future years, that cap will rise in step with the rate of change in Part D costs.

A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...

A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...

released the first set of negotiated prices for the Medicare Drug Price Negotiation Program for 2026. Authorized under the Inflation Reduction Act of 2022, this drug-pricing program marks a ...

the selection of the first 10 drugs for price negotiation by Medicare. (Photo by Nathan Posner/Anadolu Agency via Getty Images) Standing next to President Biden at a campaign event last month ...

the Centers for Medicare and Medicaid Services (CMS) released the negotiated prices, or Maximum Fair Prices (MFPs), for the first 10 pharmaceutical products selected for negotiation under the Infl ...

President Biden and Vice President Harris plan to meet in the White House Situation Room on Monday along with the U.S. hostage deal negotiating team after the murder of six hostages, including ...

It's true that these can increase costs for Medicare, but one way to offset that is suggested by another recommendation: "... ensure [that] savings achieved through drug negotiations, or by other ...

The IRA, which was brought into law in August 2022, introduced the Medicare price negotiation program. This program allowed the US Government to negotiate the prices of drugs in Medicare for the ...